Gilead Leads 3 Drug Stocks With Top Fundamentals
Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN) and Alexion Pharmaceuticals (ALXN) are the focus of the Screen of the Day: Top Fundamentals. Companies with top fundamentals are highly rated by IBD and have 3-year sales and earnings growth rates of at least 25%. Gilead broadens fight against HCV 2016 might not bring the huge drug launches seen in previous years. But Gilead Sciences, known for its highly effective, highly priced hepatitis C